Top

Published in:

01-06-2010 | Original Paper

Induction of S100B secretion in C6 astroglial cells by the major metabolites accumulating in glutaric acidemia type I

Authors: André Quincozes-Santos, Rafael Borba Rosa, Guilhian Leipnitz, Daniela Fraga de Souza, Bianca Seminotti, Moacir Wajner, Carlos Alberto Gonçalves

Published in: Metabolic Brain Disease | Issue 2/2010

Abstract

Glutaryl-CoA dehydrogenase deficiency or glutaric acidemia type I (GA I) is an inherited neurometabolic disorder biochemically characterized by tissue accumulation of predominantly glutaric (GA) and 3-hydroxyglutaric (3OHGA) acids and clinically by severe neurological symptoms and structural brain abnormalities, manifested as progressive cerebral atrophy and acute striatum degeneration following encephalopathic crises, whose pathophysiology is still in debate. Considering that reactive astrogliosis is a common finding in brain of GA I patients, in the present study we investigated the effects of GA and 3OHGA on glial activity determined by S100B release by rat C6-glioma cells. We also evaluated the effects of these organic acids on some parameters of oxidative stress in these astroglial cells. We observed that GA and 3OHGA significantly increased S100B secretion and thiobarbituric acid-reactive substances (lipid peroxidation), whereas GA markedly decreased reduced glutathione levels in these glioma cells. This is the first report demonstrating that the major metabolites accumulating in GA I activate S100B secretion in astroglial cells, indicating activation of these cells. We also showed that GA and 3OHGA induced oxidative stress in C6 lineage cells, confirming previous findings observed in brain fresh tissue. It is therefore presumed that reactive glial cells and oxidative damage may underlie at least in part the neuropathology of GA I.

Ahlemeyer B, Beier H, Semkova I, Schaper C, Krieglstein J (2000) S100β protects cultured neurons against glutamate- and staurosporine- induced damage and is involved in the antiapoptotic action of the 5HT1A-receptor agonist, Bay × 3702. Brain Res 858:121–128CrossRefPubMed

Araque A (2006) Astrocyte-neuron signaling in the brain-implications for disease. Curr Opin Investig Drugs 7:619–624PubMed

Aschner M, Allen JW, Kimelberg HK, LoPachin RM, Streit WJ (1999) Glial cells in neurotoxicity development. Annu Rev Pharmacol Toxicol 39:151–173CrossRefPubMed

Barbeito LH, Pehar M, Cassina P, Vargas MR, Peluffo H, Vieira L, Estevez AG, Beckman JS (2004) A role for astrocytes in motor neuron loss in amyotrophic lateral sclerosis. Brain Res Brain Res Rev 47:263–274CrossRefPubMed

Benda P, Lightbody J, Sato G, Levine L, Sweet W (1968) Differentiated rat glial cell strain in tissue culture. Science 161:370–371CrossRefPubMed

Bialowas-McGoey LA, Lesicka A, Whitaker-Azmitia PM (2008) Vitamin E increases S100B-mediated microglial activation in an S100B- overexpressing mouse model of pathological aging. Glia 56(16):1780–1790CrossRefPubMed

Browne RW, Armstrong D (1998) Reduced glutathione and glutathione disulfide. Methods Mol Biol 108:347–352PubMed

Cassina P, Cassina A, Pehar M, Castellanos R, Gandelman M, de León A, Robinson KM, Mason RP, Beckman JS, Barbeito L, Radi R (2008) Mitochondrial dysfunction in SOD1G93A-bearing astrocytes promotes motor neuron degeneration: prevention by mitochondrial-targeted antioxidants. J Neurosci 28:4115–4122CrossRefPubMed

Chiu SY, Kriegler S (1994) Neurotransmitter-mediated signaling between axons and glial cells. Glia 11:191–200CrossRefPubMed

Das AM (2003) Regulation of the mitochondrial ATP-synthase in health and disease. Mol Genet Metab 79:71–82CrossRefPubMed

Das AM, Lucke T, Ullrich K (2003) Glutaric aciduria I: creatine supplementation restores creatine phosphate levels in mixed cortex cells from rat incubated with 3-hydroxyglutarate. Mol Genet Metab 78:108–111CrossRefPubMed

de Almeida LM, Leite MC, Thomazi AP, Battu C, Nardin P, Tortorelli LS, Zanotto C, Posser T, Wofchuk ST, Leal RB, Gonçalves CA, Gottfried C (2008) Resveratrol protects against oxidative injury induced by H2O2 in acute hippocampal slice preparations from Wistar rats. Arch Biochem Biophys 480(1):27–32CrossRefPubMed

da Costa Ferreira G, Viegas CM, Schuck PF, Tonin A, Ribeiro CA, de Moura CD, Dalla-Costa T, Latini A, Wyse AT, Wannmacher CM, Vargas CR, Wajner M (2005) Glutaric acid administration impairs energy metabolism in midbrain and skeletal muscle of young rats. Neurochem Res 30:1123–1131CrossRef

de Mello CF, Kölker S, Ahlemeyer B, de Souza FR, Fighera MR, Mayatepek E, Krieglstein J, Hoffmann GF, Wajner M (2001) Intrastriatal administration of 3-hydroxyglutaric acid induces convulsions and striatal lesions in rats. Brain Res 916(1–2):70–75CrossRefPubMed

de Oliveira Marques F, Hagen ME, Pederzolli CD, Sgaravatti AM, Durigon K, Testa CG, Wannmacher CM, de Souza Wyse AT, Wajner M, Dutra-Filho CS (2003) Glutaric acid induces oxidative stress in brain of young rats. Brain Res 964:153–158CrossRefPubMed

Dienel GA, Hertz L (2001) Glucose and lactate metabolism during brain activation. J Neurosci Res 66:824–838CrossRefPubMed

Donato R (2001) S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. Int J Biochem Cell Biol 33(7):637–668CrossRefPubMed

Donato R, Sorci G, Riuzzi F, Arcuri C, Bianchi R, Brozzi F, Tubaro C, Giambanco I (2009) S100B’s double life: Intracellular regulator and extracellular signal. Biochim Biophys Acta 1793(6):1008–1022CrossRefPubMed

Dos Santos AQ, Nardin P, Funchal C, De Almeida LM, Jacques-Silva MC, Wofschuk ST, Gonçalves CA, Gottfried C (2006) Resveratrol increases glutamate uptake and glutamine synthetase activity in C6 glioma cells. Arch Biochem Biophys 453:161–167CrossRefPubMed

Dröge W (2002) Aging-related changes in the thiol/disulfide redox state: implications for the use of thiol antioxidants. Exp Gerontol 37(12):1333–1345CrossRefPubMed

Esterbauer H, Cheeseman KH (1990) Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. Methods Enzymol 186:407–421CrossRefPubMed

Fighera MR, Royes LF, Furian AF, Oliveira MS, Fiorenza NG, Frussa-Filho R, Petry JC, Coelho RC, Mello CF (2006) GM1 ganglioside prevents seizures, Na+, K+-ATPase activity inhibition and oxidative stress induced by glutaric acid and pentylenetetrazole. Neurobiol Dis 22:611–623CrossRefPubMed

Frizzo ME, Schwarzbold C, Porciúncula LO, Dalcin KB, Rosa RB, Ribeiro CA, Souza DO, Wajner M (2004) 3-hydroxyglutaric acid enhances glutamate uptake into astrocytes from cerebral cortex of young rats. Neurochem Int 44(5):345–353CrossRefPubMed

Funchal C, Tramontina F, Quincozes dos Santos A, Fraga de Souza D, Gonçalves CA, Pessoa-Pureur R, Wajner M (2007) Effect of the branched-chain alpha-keto acids accumulating in maple syrup urine disease on S100B release from glial cells. J Neurol Sci 260(1–2):87–94CrossRefPubMed

Funk CB, Prasad AN, Frosk P, Sauer S, Kolker S, Greenberg CR, Del Bigio MR (2005) Neuropathological, biochemical and molecular findings in a glutaric acidemia type 1 cohort. Brain 128:711–722CrossRefPubMed

Gonçalves CA, Leite MC, Nardin P (2008) Biological and methodological features for the measurement of S100B, a putative marker of brain injury. Clin Biochem 41:755–763CrossRefPubMed

Goodman SI, Frerman FE (2001) Organic acidemias due to defects in lysine oxidation: 2-ketoadipic acidemia and glutaric acidemia. In: Scriver C, Beaudet A, Sly W, Valle D (eds) The metabolic and molecular bases of inherited disease. McGraw Hill, New York, pp 2195–2004

Goodman SI, Norenberg MD, Shikes RH, Breslich DJ, Moe PG (1977) Glutaric aciduria: biochemical and morphologic considerations. J Pediatr 90(5):746–750CrossRefPubMed

Goodman SI, Frerman FE, Loehr JP (1987) Recent progress in understanding glutaric acidemias. Enzyme 38(1–4):76–79PubMed

Haghighat N, McCandless DW (1997) Effect of ammonium chloride on energy metabolism of astrocytes and C6-glioma cells in vitro. Metab Brain Dis 13(2):173

Halliwell B, Gutteridge JMC (2007a) Measurement of reactive species. In: Halliwell B, Gutteridge JMC (eds) Free radicals in biology and medicine. Oxford University Press, Oxford, pp 268–340

Halliwell B, Gutteridge JMC (2007b) Cellular responses to oxidative stress: adaptation, damage, repair, senescence and death. In: Halliwell B, Gutteridge JMC (eds) Free radicals in biology and medicine. Oxford University Press, Oxford, pp 187–267

Hoffmann GF, Zschocke J (1999) Glutaric aciduria type I: from clinical, biochemical and molecular diversity to successful therapy. J Inherit Metab Dis 22(4):381–391CrossRefPubMed

Kleindienst A, Hesse F, Bullock MR, Buchfelder M (2007) The neurotrophic protein S100B: value as a marker of brain damage and possible therapeutic implications. Prog Brain Res 161:317–325CrossRefPubMed

Koeller DM, Woontner M, Crnic LS, Kleinschmidt-DeMasters B, Stephens J, Hunt EL, Goodman SI (2002) Biochemical, pathologic and behavioral analysis of a mouse model of glutaric acidemia type I. Hum Mol Genet 11(4):347–357CrossRefPubMed

Kögel D, Peters M, König HG, Hashemi SM, Bui NT, Arolt V, Rothermundt M, Prehn JH (2004) S100B potently activates p65/c-Rel transcriptional complexes in hippocampal neurons: Clinical implications for the role of S100B in excitotoxic brain injury. Neuroscience 127(4):913–920CrossRefPubMed

Kölker S, Ahlemeyer B, Krieglstein J, Hoffmann GF (1999) 3- Hydroxyglutaric and glutaric acids are neurotoxic through NMDA receptors in vitro. J Inherit Metab Dis 22(3):259–262PubMed

Kolker S, Ahlemeyer B, Krieglstein J, Hoffmann GF (2000) Cerebral organic acid disorders induce neuronal damage via excitotoxic organic acids in vitro. Amino acids 18:31–40CrossRefPubMed

Kölker S, Kohr G, Ahlemeyer B, Okun JG, Pawlak V, Horster F, Mayatepek E, Krieglstein J, Hoffmann GF (2002) Ca(2+) and Na(+) dependence of 3-hydroxyglutarate-induced excitotoxicity in primary neuronal cultures from chick embryo telencephalons. Pediatr Res 52(2):199–206CrossRefPubMed

Kölker S, Hoffmann GF, Schor DS, Feyh P, Wagner L, Jeffrey I, Pourfarzam M, Okun JG, Zschocke J, Baric I, Bain MD, Jakobs C, Chalmers RA (2003) Glutaryl-CoA dehydrogenase deficiency: region-specific analysis of organic acids and acylcarnitines in post mortem brain predicts vulnerability of the putamen. Neuropediatrics 34(5):253–260CrossRefPubMed

Kölker S, Koeller DM, Okun JG, Hoffmann GF (2004a) Pathomechanisms of neurodegeneration in glutaryl-CoA dehydrogenase deficiency. Ann Neurol 55(1):7–12CrossRefPubMed

Kölker S, Koeller DM, Sauer S, Horster F, Schwab MA, Hoffmann GF, Ullrich K, Okun JG (2004b) Excitotoxicity and bioenergetics in glutaryl-CoA dehydrogenase deficiency. J Inherit Metab Dis 27(6):805–812CrossRefPubMed

Kölker S, Sauer SW, Surtees RA, Leonard JV (2006) The aetiology of neurological complications of organic acidaemias—a role for the blood-brain barrier. J Inherit Metab Dis 29(6):701–704CrossRefPubMed

Korfias S, Stranjalis G, Papadimitriou A, Psachoulia C, Daskalakis G, Antsaklis A, Sakas DE (2006) Serum S-100B protein as a biochemical marker of brain injury: a review of current concepts. Curr Med Chem 13:3719–3731CrossRefPubMed

Külkens S, Harting I, Sauer S, Zschocke J, Hoffmann GF, Gruber S, Bodamer OA, Kölker S (2005) Late-onset neurologic disease in glutaryl-CoA dehydrogenase deficiency. Neurology 64(12):2142–2144CrossRefPubMed

Latini A, Borba Rosa R, Scussiato K, Llesuy S, Belló-Klein A, Wajner M (2002) 3-Hydroxyglutaric acid induces oxidative stress and decreases the antioxidant defenses in cerebral cortex of young rats. Brain Res 956(2):367–373CrossRefPubMed

Latini A, Scussiato K, Leipnitz G, Dutra-Filho CS, Wajner M (2005a) Promotion of oxidative stress by 3-hydroxyglutaric acid in rat striatum. J Inherit Metab Dis 28(1):57–67CrossRefPubMed

Latini A, Rodriguez M, Borba Rosa R, Scussiato K, Leipnitz G, Reis de Assis D, da Costa Ferreira G, Funchal C, Jacques-Silva MC, Buzin L, Giugliani R, Cassina A, Radi R, Wajner M (2005b) 3- Hydroxyglutaric acid moderately impairs energy metabolism in brain of young rats. Neuroscience 135(1):111–120CrossRefPubMed

Latini A, Ferreira GC, Scussiato K, Schuck PF, Solano AF, Dutra-Filho CS, Vargas CR, Wajner M (2007) Induction of oxidative stress by chronic and acute glutaric acid administration to rats. Cell Mol Neurobiol 27:423–438CrossRefPubMed

Leite MC, Brolese G, Almeida LMV, Pinero CC, Gottfried C, Gonçalves CA (2006) Ammonia-induced alteration in S100B secretion in astrocytes is not reversed by creatine addition. Brain Res Bull 70:179–185CrossRefPubMed

Leite MC, Galland F, Brolese G, Guerra MC, Bortolotto JW, Freitas R, Almeida LM, Gottfried C, Gonçalves CA (2008) A simple, sensitive and widely applicable ELISA for S100B: methodological features of the measurement of this glial protein. J Neurosci Methods 169:93–99PubMed

Lowry OH, Rosebrough NJ, Lewis-Farr A, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275PubMed

Mangoura D, Sakellaridis N, Jones J, Vernadakis A (1989) Early and late passage C-6 glial cell growth: similarities with primary glial cells in culture. Neurochem Res 14(10):941–947CrossRefPubMed

Nardin P, Tramontina F, Leite MC, Tramontina AC, Quincozes-Santos A, de Almeida LM, Battastini AM, Gottfried C, Gonçalves CA (2007) S100B content and secretion decrease in astrocytes cultured in high-glucose medium. Neurochem Int 50(5):774–782CrossRefPubMed

Porciúncula LO, Emanuelli T, Tavares RG, Schwarzbold C, Frizzo ME, Souza DO, Wajner M (2004) Glutaric acid stimulates glutamate binding and astrocytic uptake and inhibits vesicular glutamate uptake in forebrain from young rats. Neurochem Int 45(7):1075–1086CrossRefPubMed

Quincozes-Santos A, Andreazza AC, Nardin P, Funchal C, Gonçalves CA, Gottfried C (2007) Resveratrol attenuated oxidative- induced DNA damage in C6 glioma cells. Neurotoxicology 28:886–889CrossRefPubMed

Quincozes-Santos A, Abib RT, Leite MC, Bobermin D, Bambini-Junior V, Gonçalves CA, Riesgo R, Gottfried C (2008) Effect of the atypical neuroleptic risperidone on morphology and S100B secretion in C6 astroglial lineage cells. Mol Cell Biochem 314:59–63CrossRefPubMed

Quincozes-Santos A, Nardin P, de Souza DF, Gelain DP, Moreira JC, Latini A, Gonçalves CA, Gottfried C (2009) The janus face of resveratrol in astroglial cells. Neurotox Res 16(1):30–41CrossRefPubMed

Ridet JL, Malhotra SK, Privat A, Gage FH (1997) Reactive astrocytes: cellular and molecular clues to biological function. Trends Neurosci 20:570–577CrossRefPubMed

Rosa RB, Schwarzbold C, Dalcin KB, Ghisleni GC, Ribeiro CA, Moretto MB, Frizzo ME, Hoffmann GF, Souza DO, Wajner M (2004) Evidence that 3-hydroxyglutaric acid interacts with NMDA receptors in synaptic plasma membranes from cerebral cortex of young rats. Neurochem Int 45(7):1087–1094CrossRefPubMed

Rothermundt M, Peters M, Prehn JH, Arolt V (2003) S100B in brain damage and neurodegeneration. Microsc Res Tech 60:614–632CrossRefPubMed

Sauer SW (2007) Biochemistry and bioenergetics of glutaryl-CoA dehydrogenase deficiency. J Inherit Metab Dis 30:673–680CrossRefPubMed

Sauer SW, Okun JG, Schwab MA, Crnic LR, Hoffmann GF, Goodman SI, Koeller DM, Kölker S (2005) Bioenergetics in glutaryl- coenzyme A dehydrogenase deficiency: a role for glutaryl-coenzyme A. J Biol Chem 280:21830–21836CrossRefPubMed

Schulpis KH, Kariyannis C, Papassotiriou I (2004) Serum levels of neural protein S-100B in phenylketonuria. Clin Biochem 37:76–79CrossRefPubMed

Silva CG, Silva AR, Ruschel C, Helegda C, Wyse AT, Wannmacher CM, Dutra-Filho CS, Wajner M (2000) Inhibition of energy production in vitro by glutaric acid in cerebral cortex of young rats. Metab Brain Dis 15(2):123–131CrossRefPubMed

Simpson JE, Fernando MS, Clark L, Ince PG, Matthews F, Forster G, O'Brien JT, Barber R, Kalaria RN, Brayne C, Shaw PJ, Lewis CE, Wharton SB (2007) MRC cognitive function and ageing neuropathology study group. White matter lesions in an unselected cohort of the elderly: astrocytic, microglial and oligodendrocyte precursor cell responses. Neuropathol Appl Neurobiol 33(4):410–419CrossRefPubMed

Smale G, Nichols NR, Brady DR, Finch CE, Horton WEJ (1995) Evidence for apoptotic cell death in Alzheimer’s disease. Exp Neurol 133:225–30CrossRefPubMed

Sonnewald U, Qu H, Aschner M (2002) Pharmacology and toxicology of astrocyte–neuron glutamate transport and cycling. J Pharmacol Exp Ther 301:1–6CrossRefPubMed

Strauss KA, Morton DH (2003) Type I glutaric aciduria, part 2: a model of acute striatal necrosis. Am J Med Genet C Semin Med Genet 121C(1):53–70CrossRefPubMed

Strauss KA, Puffenberger EG, Robinson DL, Morton DH (2003) Type I glutaric aciduria, part 1: natural history of 77 patients. Am J Med Genet C Semin Med Genet 121C(1):38–52CrossRefPubMed

Ullrich K, Flott-Rahmel B, Schluff P, Musshoff U, Das A, Lucke T, Steinfeld R, Christensen E, Jakobs C, Ludolph A, Neu A, Roper R (1999) Glutaric aciduria type I: pathomechanisms of neurodegeneration. J Inherit Metab Dis 22(4):392–403CrossRefPubMed

Vernadakis A, Lee K, Kentroti S, Brodie C (1992) Role of astrocytes in aging: late passage primary mouse brain astrocytes and C6-glial cells as models. Prog Brain Res 94:391–409CrossRefPubMed

Wajner M, Kölker S, Souza DO, Hoffmann GF, Mello CF (2004) Modulation of glutamatergic and GABAergic neurotransmission in glutaryl-CoA dehydrogenase deficiency. J Inherit Metab Dis 27(6):825–828CrossRefPubMed

Wang DD, Bordey A (2008) The astrocyte odyssey. Prog Neurobiol 86(4):342–367PubMed

Wiltfang J, Nolte W, Otto M, Wildberg J, Bahn E, Figulla HR, Pralle L, Hartmann H, Rüther E, Ramadori G (1999) Elevated serum levels of astroglial S100 beta in patients with liver cirrhosis indicate early and subclinical portal-systemic encephalopathy. Metab Brain Dis 14:239–251CrossRefPubMed

Zinnanti WJ, Lazovic J, Wolpert EB, Antonetti DA, Smith MB, Connor JR, Woontner M, Goodman SI, Cheng KC (2006) A diet- induced mouse model for glutaric aciduria type I. Brain 129(Pt 4):899–910CrossRefPubMed

Zinnanti WJ, Lazovic J, Housman C, LaNoue K, O’Callaghan JP, Simpson I, Woontner M, Goodman SI, Connor JR, Jacobs RE, Cheng KC (2007) Mechanism of age-dependent susceptibility and novel treatment strategy in glutaric acidemia type I. J Clin Invest 117:3258–3270CrossRefPubMed

Title: Induction of S100B secretion in C6 astroglial cells by the major metabolites accumulating in glutaric acidemia type I
Authors: André Quincozes-Santos
Rafael Borba Rosa
Guilhian Leipnitz
Daniela Fraga de Souza
Bianca Seminotti
Moacir Wajner
Carlos Alberto Gonçalves
Publication date: 01-06-2010
Publisher: Springer US
Published in: Metabolic Brain Disease / Issue 2/2010
Print ISSN: 0885-7490
Electronic ISSN: 1573-7365
DOI: https://doi.org/10.1007/s11011-010-9203-0

2024 ASCO Annual Meeting

Springer Medicine

Induction of S100B secretion in C6 astroglial cells by the major metabolites accumulating in glutaric acidemia type I

Abstract

2024 ASCO Annual Meeting

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 2/2010

Ozone modulates the effects of imipramine on immobility in the forced swim test, and nonspecific parameters of hippocampal oxidative stress in the rat

Chronic variable stress impairs energy metabolism in prefrontal cortex and hippocampus of rats: prevention by chronic antioxidant treatment

Generalized seizures aggravated by levetiracetam in an adult patient with phenylketonuria

Acute administration of 5-oxoproline induces oxidative damage to lipids and proteins and impairs antioxidant defenses in cerebral cortex and cerebellum of young rats

Split-brain syndrome after hepatic transplantation: a tacrolimus-related vasculitis?

Inhibition of mitochondrial respiratory chain in the brain of rats after renal ischemia is prevented by N-acetylcysteine and deferoxamine